Article ; Online: Reply to T.J. Kruser et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2016 Volume 34, Issue 11, Page(s) 1282–1283
MeSH term(s) | Angiogenesis Inhibitors/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Agents, Alkylating/therapeutic use ; Bevacizumab/therapeutic use ; Brain Neoplasms/drug therapy ; Brain Neoplasms/mortality ; Brain Neoplasms/therapy ; Chemoradiotherapy ; Dacarbazine/analogs & derivatives ; Female ; Glioblastoma/drug therapy ; Glioblastoma/mortality ; Glioblastoma/therapy ; Humans ; Male ; Quality of Life |
---|---|
Chemical Substances | Angiogenesis Inhibitors ; Antibodies, Monoclonal, Humanized ; Antineoplastic Agents, Alkylating ; Bevacizumab (2S9ZZM9Q9V) ; Dacarbazine (7GR28W0FJI) |
Language | English |
Publishing date | 2016-04-10 |
Publishing country | United States |
Document type | Comment ; Letter |
ZDB-ID | 604914-x |
ISSN | 1527-7755 ; 0732-183X |
ISSN (online) | 1527-7755 |
ISSN | 0732-183X |
DOI | 10.1200/JCO.2015.65.2438 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1847: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 650: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.